コンパニオンアニマル変形性関節症の市場規模、シェア、動向分析レポート：製品別、動物別、投与経路別、最終用途別、地域別、セグメント予測、2025年～2033年

コンパニオンアニマル変形性関節症市場の概要

コンパニオンアニマル変形性関節症の世界市場規模は、2024年に22億9,000万米ドルと推定され、2033年には132億7,000万米ドルに達すると予測され、2025～2033年のCAGRは23.5%で成長すると予測されています。市場を牽引すると予想される主要因には、変形性関節症の有病率の上昇、研究開発イニシアチブの増加、新規治療法の出現、啓発キャンペーンの増加、診断技術の進歩による変形性関節症（OA）治療の採用増加などがあります。

コンパニオンアニマル、特にイヌ、ネコ、ウマにおける変形性関節症（OA）の有病率の上昇は、世界のコンパニオンアニマル変形性関節症市場を大きく牽引しています。イヌだけを見ても、1歳以上のイヌの約20％にOA（変形性関節症）の臨床徴候が見られると推定されており、臨床観察とX線検査の両方によると、この有病率は高齢のイヌでは80％にまでエスカレートする可能性があります。同様の動向はネコでも観察され、OAが過小診断されることが多いが、高齢化したネコの個体群ではますます認知されるようになっており、12歳以上のネコの最大90％にX線学的徴候が認められるという研究もあります。馬のOAもまた、特にスポーツ馬や競走馬において、成績低下や早期引退の主要原因となっています。

このようなOA有病率の増加には、栄養学や獣医療的ケアの進歩によるペットの寿命延長、肥満率（OAの主要な危険因子）の上昇、獣医師や飼い主の認識や診断能力の向上など、いくつかの要因が寄与しています。こうした動向により、早期診断、慢性疾患管理、疼痛緩和ソリューションに対する需要が拡大しています。

このような負担の増大は、新規の生物製剤、再生療法（幹細胞や多血小板血漿など）、モノクローナル抗体（ZoetisのLibrelaやSolensiaなど）、その他の複合的疼痛管理アプローチの開発など、OA治療への多大な投資と技術革新を促しています。製薬会社やバイオテクノロジー企業は、特にペットの飼い主がプレミアムケアや予防ケアを求めるようになっていることから、より良いコンプライアンスとペットの生活の質の向上を提供する長時間作用型の標的療法を積極的に開発しています。これと並行して、動物病院への受診が急増し、運動機能のモニタリングやウェルネスプログラムが重視されるようになったことで、診断薬、サプリメント、関節サポート食、リハビリテーションサービスなどの市場も堅調に推移しています。

これらの疫学的、行動学的要因を総合すると、コンパニオンアニマルOAの患者層が拡大しているだけでなく、この疾患は世界の動物医療産業の基幹セグメントへと変貌を遂げつつあり、治療、診断薬、支持療法ソリューションに長期的な成長機会がもたらされています。

LibrelaのようなOAを対象とするモノクローナル抗体は市場で好調に推移し、広く採用されているにもかかわらず、最近、全面的な禁止を求める声や、筋骨格系の有害事象が9倍増加したことを示唆する新たなデータなど、社会的な論争が巻き起こっており、評判や規制上の課題となっています。FDAやEMAのような規制当局からのモニタリングが強化された結果、市販後のモニタリングが厳しくなり、ラベルの改訂や配合の制限が行われる可能性があります。短期的には、獣医師やペットの飼い主は既存の非ステロイド性抗炎症薬やサプリメントなど、より保守的な選択肢に軸足を移すかもしれず、生物製剤セグメントの成長が鈍化する可能性があります。しかし、透明性の高い安全性検査、ファーマコビジランスの改善、明確なリスク・ベネフィット・ガイドラインが信頼を回復し、最終的にはOA治療としてのmAb療法の地位を確固たるものにする可能性があります。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 コンパニオンアニマル変形性関節症市場の変動動向と展望

• 市場系統の展望
  • 親市場
  • 補助市場
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• コンパニオンアニマル変形性関節症市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析
  • 主要国による規制枠組み
  • 主要国別、主要種による動物推定個体数（2021～2024年）
  • パイプライン/臨床検査分析
  • COVID-19の影響分析

第4章 コンパニオンアニマル変形性関節症市場：製品別、推定・動向分析

• セグメントダッシュボード
• コンパニオンアニマル変形性関節症市場：製品変動分析
• コンパニオンアニマル変形性関節症市場規模と動向分析（製品別、2021～2033年）
• 生物製剤
  • 幹細胞
  • 多血小板血漿（多血小板血漿）
  • モノクローナル抗体（mAb）
  • その他の生物製剤
• 粘性サプリメント
• 医薬品
  • ステロイド
  • NSAIDs
  • その他
• 栄養補助食品

第5章 コンパニオンアニマル変形性関節症市場：動物別、推定・動向分析

• セグメントダッシュボード
• コンパニオンアニマル変形性関節症市場：動物変動分析
• コンパニオンアニマル変形性関節症市場規模と動向分析（動物別、2021～2033年）
• 犬
• 猫
• 馬

第6章 コンパニオンアニマル変形性関節症市場：投与経路別、推定・動向分析

• セグメントダッシュボード
• コンパニオンアニマル変形性関節症市場：投与経路変動分析
• コンパニオンアニマル変形性関節症市場規模と動向分析（投与経路別、2021～2033年）
  • 経口
  • 注射剤
  • 筋肉内
  • 関節内
  • その他の注射剤
  • その他

第7章 コンパニオンアニマル変形性関節症市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• コンパニオンアニマル変形性関節症市場：最終用途変動分析
• コンパニオンアニマル変形性関節症市場規模と動向分析（最終用途別、2021～2033年）
  • 動物病院/クリニック
  • eコマース
  • その他

第8章 コンパニオンアニマル変形性関節症市場：地域別、推定・動向分析

• 地域ダッシュボード
• コンパニオンアニマル変形性関節症市場シェア（地域別、2024年と2033年）
• 地域展望
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 市場参入企業の分類
• 企業の市況分析/ヒープマップ分析
• 企業プロファイル
  • Zoetis
  • Boehringer Ingelheim
  • Elanco Animal Health
  • American Regent, Inc.
  • Merck Animal Health（Merck & Co. Inc）
  • Vetoquinol SA
  • Ceva Sante Animale
  • Virbac
  • Biogenesis Bago
  • Ardent Animal Health, Llc
  • PetVivo Holdings, Inc.（Spryng）
  • VetStem Inc.
  • Enso Discoveries
  • Contura Vet US
  • T-Cyte Therapeutics
  • Medrego Llc.
• 戦略マッピング
  • 合併と買収
• パートナーシップとコラボレーション
• 拡大
• 製品発売
• 製品承認
• その他

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 4 Global Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 5 Global Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 6 Global Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 7 Global Companion Animal Osteoarthritis Market, by Region, 2021 - 2033 (USD Million)
• Table 8 North America Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
• Table 9 North America Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 10 North America Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 11 North America Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 12 North America Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 13 U.S. Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 14 U.S. Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 15 U.S. Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 16 U.S. Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 17 Canada Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 18 Canada Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 19 Canada Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 20 Canada Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 21 Mexico Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 22 Mexico Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 23 Mexico Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 24 Mexico Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 25 Europe Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
• Table 26 Europe Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 27 Europe Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 28 Europe Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 29 Europe Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 30 UK Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 31 UK Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 32 UK Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 33 UK Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 34 Germany Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 35 Germany Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 36 Germany Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 37 Germany Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 38 France Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 39 France Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 40 France Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 41 France Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 42 Italy Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 43 Italy Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 44 Italy Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 45 Italy Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 46 Spain Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 47 Spain Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 48 Spain Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 49 Spain Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 50 Denmark Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 51 Denmark Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 52 Denmark Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 53 Denmark Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 54 Sweden Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 55 Sweden Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 56 Sweden Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 57 Sweden Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 58 Norway Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 59 Norway Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 60 Norway Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 61 Norway Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 62 Asia Pacific Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
• Table 63 Asia Pacific Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 64 Asia Pacific Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 65 Asia Pacific Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 66 Asia Pacific Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 67 China Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 68 China Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 69 China Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 70 China Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 71 Japan Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 72 Japan Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 73 Japan Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 74 Japan Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 75 India Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 76 India Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 77 India Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 78 India Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 79 South Korea Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 80 South Korea Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 81 South Korea Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 82 South Korea Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 83 Australia Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 84 Australia Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 85 Australia Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 86 Australia Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 87 Thailand Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 88 Thailand Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 89 Thailand Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 90 Thailand Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 91 Latin America Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
• Table 92 Latin America Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 93 Latin America Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 94 Latin America Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 95 Latin America Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 96 Brazil Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 97 Brazil Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 98 Brazil Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 99 Brazil Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 100 Brazil Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 101 Argentina Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 102 Argentina Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 103 Argentina Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 104 Middle East & Africa Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
• Table 105 Middle East & Africa Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 106 Middle East & Africa Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 107 Middle East & Africa Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 108 Middle East & Africa Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 109 South Africa Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 110 South Africa Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 111 South Africa Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 112 South Africa Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 113 Saudi Arabia Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 114 Saudi Arabia Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 115 Saudi Arabia Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 116 Saudi Arabia Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 117 UAE Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 118 UAE Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 119 UAE Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 120 UAE Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Table 121 Kuwait Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Table 122 Kuwait Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Table 123 Kuwait Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
• Table 124 Kuwait Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Companion Animal Osteoarthritis Market, Market Segmentation
• Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Regional Marketplace: Key Takeaways
• Fig. 14 Global Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
• Fig. 15 Global Companion Animal Osteoarthritis Market, for Biologics, 2021 - 2033 (USD Million)
• Fig. 16 Global Companion Animal Osteoarthritis Market, for Stem Cells, 2021 - 2033 (USD Million)
• Fig. 17 Global Companion Animal Osteoarthritis Market, for Platelet-Rich Plasma (PRP), 2021 - 2033 (USD Million)
• Fig. 18 Global Companion Animal Osteoarthritis Market, for Monoclonal Antibodies (mAb), 2021 - 2033 (USD Million)
• Fig. 19 Global Companion Animal Osteoarthritis Market, for Other Biologics, 2021 - 2033 (USD Million)
• Fig. 20 Global Companion Animal Osteoarthritis Market, for Viscosupplements, 2021 - 2033 (USD Million)
• Fig. 21 Global Companion Animal Osteoarthritis Market, for Pharmaceuticals, 2021 - 2033 (USD Million)
• Fig. 22 Global Companion Animal Osteoarthritis Market, for Steroids, 2021 - 2033 (USD Million)
• Fig. 23 Global Companion Animal Osteoarthritis Market, for NSAIDS, 2021 - 2033 (USD Million)
• Fig. 24 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
• Fig. 25 Global Companion Animal Osteoarthritis Market, for Nutritional Supplements, 2021 - 2033 (USD Million)
• Fig. 26 Global Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
• Fig. 27 Global Companion Animal Osteoarthritis Market, for Canine, 2021 - 2033 (USD Million)
• Fig. 28 Global Companion Animal Osteoarthritis Market, for Equine, 2021 - 2033 (USD Million)
• Fig. 29 Global Companion Animal Osteoarthritis Market, for Feline, 2021 - 2033 (USD Million)
• Fig. 30 Global Companion Animal Osteoarthritis Market, for By Route of Administration, 2021 - 2033 (USD Million)
• Fig. 31 Global Companion Animal Osteoarthritis Market, for Oral, 2021 - 2033 (USD Million)
• Fig. 32 Global Companion Animal Osteoarthritis Market, for Injectable, 2021 - 2033 (USD Million)
• Fig. 33 Global Companion Animal Osteoarthritis Market, for Intra-muscular, 2021 - 2033 (USD Million)
• Fig. 34 Global Companion Animal Osteoarthritis Market, for Intra-articular, 2021 - 2033 (USD Million)
• Fig. 35 Global Companion Animal Osteoarthritis Market, for Other Injectable, 2021 - 2033 (USD Million)
• Fig. 36 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
• Fig. 37 Global Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
• Fig. 38 Global Companion Animal Osteoarthritis Market, for Veterinary Hospitals/Clinics, 2021 - 2033 (USD Million)
• Fig. 39 Global Companion Animal Osteoarthritis Market, for E-commerce, 2021 - 2033 (USD Million)
• Fig. 40 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
• Fig. 41 Regional Outlook, 2024 & 2033
• Fig. 42 North America Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 43 U.S. Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 44 Canada Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 45 Mexico Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 46 Europe Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 47 UK Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 48 Germany Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 49 France Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 50 Italy Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 51 Spain Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 52 Sweden Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 53 Denmark Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 54 Norway Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 55 Asia Pacific Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 56 Japan Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 57 China Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 58 India Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 59 Australia Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 60 South Korea Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 61 Thailand Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 62 Latin America Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 63 Brazil Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 64 Argentina Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 65 Middle East and Africa Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 66 South Africa Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 67 Saudi Arabia Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 68 UAE Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
• Fig. 69 Kuwait Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)

Companion Animal Osteoarthritis Market Summary

The global companion animal osteoarthritis market size was estimated at USD 2.29 billion in 2024 and is projected to reach USD 13.27 billion by 2033, growing at a CAGR of 23.5% from 2025 to 2033. Key factors expected to drive the market include the rising prevalence of osteoarthritis, increasing R&D initiative, emerging novel treatments, increasing awareness campaigns, and advancing diagnostic techniques increasing adoption of osteoarthritis (OA) treatment.

The rising prevalence of osteoarthritis (OA) in companion animals-particularly dogs, cats, and horses-is significantly driving the global companion animal osteoarthritis market. In canines alone, estimates suggest that approximately 20% of dogs over one year of age show clinical signs of OA, and this prevalence can escalate to as high as 80% in older dogs, according to both clinical observations and radiographic studies. Similar trends are observed in felines, where OA is often underdiagnosed but increasingly recognized in aging cat populations, with some studies indicating radiographic signs in up to 90% of cats over 12 years old. Equine OA also remains a leading cause of reduced performance and early retirement, especially in sport and racehorses.

Several factors are contributing to this increase in OA prevalence, including extended pet lifespans due to advances in nutrition and veterinary care, rising rates of obesity (a major OA risk factor), and improved awareness and diagnostic capabilities among veterinarians and pet owners. These trends are expanding the demand for early diagnosis, chronic disease management, and pain relief solutions.

This growing burden has catalyzed significant investment and innovation in OA therapeutics, including the development of novel biologics, regenerative therapies (e.g., stem cells and PRP), monoclonal antibodies (such as Zoetis' Librela and Solensia), and other multimodal pain management approaches. Pharmaceutical and biotech companies are actively developing long-acting, targeted therapies that offer better compliance and improved quality of life for pets, particularly as pet owners increasingly seek premium and preventative care. In parallel, the surge in veterinary visits and emphasis on mobility monitoring and wellness programs is reinforcing a robust market for diagnostics, supplements, joint-support diets, and rehabilitation services.

Altogether, these epidemiological and behavioral factors are not only expanding the companion animal OA patient pool but are also transforming the disease into a cornerstone segment of the global animal health industry-creating long-term growth opportunities across therapeutics, diagnostics, and supportive care solutions.

Despite strong market performance and widespread adoption of OA-targeting monoclonal antibodies like Librela, the recent public controversy-including calls for outright bans and new data suggesting a nine fold increase in musculoskeletal adverse events-poses a reputational and regulatory challenge. Heightened scrutiny from regulators like the FDA and EMA may result in tougher post market surveillance, label revisions, or prescribing restrictions. In the short term, veterinarians and pet owners might pivot toward more conservative options, such as established NSAIDs or supplements, potentially slowing growth in the biologics segment. However, transparent safety studies, improved pharmacovigilance, and clear risk-benefit guidelines could restore confidence and ultimately solidify the position of mAb therapies as a premium OA treatment-assuming manufacturers respond proactively

Global Companion Animal Osteoarthritis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the companion animal osteoarthritis market report based on product, animal, route of administration, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Biologics
  • Stem Cells
  • Platelet-Rich Plasma (PRP)
  • Monoclonal Antibodies (mAb)
  • Other Biologics
• Viscosupplements
• Pharmaceuticals
  • Steroids
  • NSAIDS
  • Others
• Nutritional Supplements
• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Canine
• Equine
• Feline
• Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
• Oral
• Injectable
  • Intra-muscular
  • Intra-articular
  • Other Injectable
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Veterinary Hospitals/Clinics
• E-commerce
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • India
  • China
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Companion Animal Osteoarthritis Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising Prevalence of Osteoarthitis
    • 3.2.1.2. Increasing R&D Initiatives
    • 3.2.1.3. Emerging Novel Treatments
    • 3.2.1.4. Increasing Awareness Campaigns
    • 3.2.1.5. Advancing Diagnostic Techniques Increasing Adoption of OA Treatment
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Regulatory Hurdles
    • 3.2.2.2. Emerging Adverse Drug Reactions (ADR)
    • 3.2.2.3. Stringent Regulations
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Companion Animal Osteoarthritis Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
  • 3.3.3. Regulatory Framework by Key Countries
  • 3.3.4. Estimated Animal Population, by Key Species, by Key Countries, 2021-2024
  • 3.3.5. Pipeline/ Clinical Trials Analysis
  • 3.3.6. COVID-19 Impact Analysis

Chapter 4. Companion Animal Osteoarthritis Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Companion Animal Osteoarthritis Market: Product Movement Analysis
• 4.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million)
• 4.4. Biologics
  • 4.4.1. Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Stem Cells
    • 4.4.2.1. Stem Cells Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Platelet-Rich Plasma (PRP)
    • 4.4.3.1. Platelet-Rich Plasma (PRP) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Monoclonal Antibodies (mAb)
    • 4.4.4.1. Monoclonal Antibodies (mAb) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.5. Other Biologics
    • 4.4.5.1. Other Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Viscosupplements
  • 4.5.1. Viscosupplements Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Pharmaceuticals
  • 4.6.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.2. Steroids
    • 4.6.2.1. Steroids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.3. NSAIDs
    • 4.6.3.1. NSAIDs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.4. Others
    • 4.6.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Nutritional Supplements
  • 4.7.1. Nutritional Supplements Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Companion Animal Osteoarthritis Market: Animal Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Companion Animal Osteoarthritis Market: Animal Movement Analysis
• 5.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by animal, 2021 to 2033 (USD Million)
• 5.4. Canine
  • 5.4.1. Canine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Feline
  • 5.5.1. Feline Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Equine
  • 5.6.1. Equine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Companion Animal Osteoarthritis Market: By Route of Administration Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Companion Animal Osteoarthritis Market: By Route of Administration Movement Analysis
• 6.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by route of administration, 2021 to 2033 (USD Million)
  • 6.3.1. Oral
    • 6.3.1.1. Oral Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. Injectables
    • 6.3.2.1. Injectables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. Intra-muscular
    • 6.3.3.1. Intra-muscular Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.4. Intra-articular
    • 6.3.4.1. Intra-articular Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.5. Other Injectables
    • 6.3.5.1. Other Injectables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.6. Others
    • 6.3.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Companion Animal Osteoarthritis Market: By End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Companion Animal Osteoarthritis Market: By End Use Movement Analysis
• 7.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by end use, 2021 to 2033 (USD Million)
  • 7.3.1. Veterinary Hospitals/Clinics
    • 7.3.1.1. Veterinary Hospitals/Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. E-commerce
    • 7.3.2.1. E-commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Others
    • 7.3.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Companion Animal Osteoarthritis Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Companion Animal Osteoarthritis Market Share, By Region, 2024 & 2033 (USD Million)
• 8.3. Regional Outlook
• 8.4. North America
  • 8.4.1. North America Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. U.S. Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Canada Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Mexico Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. UK Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Germany Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. France Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Italy Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Spain Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Denmark Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Sweden Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Norway Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Japan Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. China Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. India Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Australia Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. South Korea Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Thailand Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Brazil Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Argentina Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 8.8. Middle East & Africa
  • 8.8.1. Middle East & Africa Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. South Africa Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Saudi Arabia Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. UAE Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Kuwait Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Company Market Position Analysis/ Heap Map Analysis
• 9.3. Company Profiles
  • 9.3.1. Zoetis
    • 9.3.1.1. Participant's Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Boehringer Ingelheim
    • 9.3.2.1. Participant's Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Elanco Animal Health
    • 9.3.3.1. Participant's Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. American Regent, Inc.
    • 9.3.4.1. Participant's Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Merck Animal Health (Merck & Co. Inc)
    • 9.3.5.1. Participant's Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Vetoquinol S.A.
    • 9.3.6.1. Participant's Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Ceva Sante Animale
    • 9.3.7.1. Participant's Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Product Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Virbac
    • 9.3.8.1. Participant's Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Product Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. Biogenesis Bago
    • 9.3.9.1. Participant's Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Product Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. Ardent Animal Health, Llc
    • 9.3.10.1. Participant's Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Product Benchmarking
    • 9.3.10.4. Strategic Initiatives
  • 9.3.11. PetVivo Holdings, Inc. (Spryng)
    • 9.3.11.1. Participant's Overview
    • 9.3.11.2. Financial Performance
    • 9.3.11.3. Product Benchmarking
    • 9.3.11.4. Strategic Initiatives
  • 9.3.12. VetStem Inc.
    • 9.3.12.1. Participant's Overview
    • 9.3.12.2. Financial Performance
    • 9.3.12.3. Product Benchmarking
    • 9.3.12.4. Strategic Initiatives
  • 9.3.13. Enso Discoveries
    • 9.3.13.1. Participant's Overview
    • 9.3.13.2. Financial Performance
    • 9.3.13.3. Product Benchmarking
    • 9.3.13.4. Strategic Initiatives
  • 9.3.14. Contura Vet US
    • 9.3.14.1. Participant's Overview
    • 9.3.14.2. Financial Performance
    • 9.3.14.3. Product Benchmarking
    • 9.3.14.4. Strategic Initiatives
  • 9.3.15. T-Cyte Therapeutics
    • 9.3.15.1. Participant's Overview
    • 9.3.15.2. Financial Performance
    • 9.3.15.3. Product Benchmarking
    • 9.3.15.4. Strategic Initiatives
  • 9.3.16. Medrego Llc.
    • 9.3.16.1. Participant's Overview
    • 9.3.16.2. Financial Performance
    • 9.3.16.3. Product Benchmarking
    • 9.3.16.4. Strategic Initiatives
• 9.4. Strategy Mapping
  • 9.4.. Mergers & Acquisitions
  • 9.4.2. Partnerships & Collaborations
  • 9.4.3. Expansion
  • 9.4.4. Product launch
  • 9.4.5. Product Approval
  • 9.4.6. Others
• 9.5. List of Key Companies
  • 9.5.1. List of Manufacturers
  • 9.5.2. List of Distributors